2m 2m 2m 2m 2m 2m 2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$35.40+$0.89 (+2.58%)
Price as of Jul 14, 2026 4:18 AM EDT- $25.7BMarket Cap
- 196.73%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$35.40+$0.89 (+2.58%)
ROIV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $34.51 | ||
Change | -$1.46 (-4.06%) | ||
Open | $35.34 | ||
High | $35.62 | ||
Low | $34.38 | ||
Previous Close | $35.97 | ||
Volume | 4,774,574 | ||
30-Day Average Volume | 6,603,297 | ||
1-Week Change | -2.49% | ||
1-Month Change | 14.88% | ||
1-Year Change | 196.73% | ||
3-Year Change | 197.50% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 713.5M | ||
Total Assets | $5.7B | ||
Market Cap | $25.7B | ||
Enterprise Value | $24.2B | ||
Period: QTR TTM FY | |||
Revenue | $2.5M | ||
Net Income | $303.0M | ||
Free Cash Flow | -$165.1M | ||
EBIT | $401.3M | ||
EBITDA | $402.0M | ||
Net Working Capital | $4.9B | ||
EPS | $0.42 | ||
Enterprise Value/EBITDA | 60 | ||
Enterprise Value/Revenue | 9,622 | ||
P/B | 6 | ||
P/E | 85 | ||
PEG | 0 | ||
Price/Free Cash Flow | -155 | ||
Price/Operating Cash Flow | -157 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue